Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine, 5-Fluorouracil, and Leucovorin in Biliary Tract and Gallbladder Cancer
NCT00009893Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- May 2001
- Primary completion
- Jan 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, fluorouracil, folinic acid in biliary tract carcinoma (BTC), gallbladder carcinoma, sponsored by Cancer and Leukemia Group B. Started May 2001; status: completed.
02
Drugs
gemcitabinefluorouracilfolinic acid
03
Conditions
biliary tract carcinoma (BTC)gallbladder carcinoma
Beyond the preview
Go deeper on NCT00009893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00009893.